Screener
Acadia Pharmaceuticals ACAD Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Product sales, net | $307,959 | $264,566 | $576,021 | $508,882 |
| Total revenues | 307,959 | 264,566 | 576,021 | 508,882 |
| Operating expenses | ||||
| Cost of product sales | 28,316 | 20,734 | 53,107 | 41,126 |
| Research and development | 81,555 | 77,951 | 158,423 | 156,216 |
| Selling, general and administrative | 160,252 | 133,507 | 331,271 | 259,877 |
| Total operating expenses | 270,123 | 232,192 | 542,801 | 457,219 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's total revenue?
- Acadia Pharmaceuticals (ACAD) reported total revenue of $307.96M in Q2 2026.
- How has Acadia Pharmaceuticals's total revenue changed year-over-year?
- Acadia Pharmaceuticals's total revenue increased by 16.4% year-over-year, from $264.57M to $307.96M.
- What is the long-term trend for Acadia Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's total revenue has grown at a 22.0% compound annual growth rate (CAGR), from $484.15M to $1.07B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Acadia Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude